Respiratory viral infections research
Respiratory viral infections research is a research topic within Epidemiology. Science Explorer counts 50k research works in it since 1950. 21.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the epidemiology, pathogenesis, and clinical impact of respiratory viral infections, with a focus on Respiratory Syncytial Virus (RSV), Human Metapneumovirus, bronchiolitis, viral pneumonia, and influenza virus. It covers topics such as disease burden, vaccine development, host immune response, and the impact of these infections on different age groups.
- Respiratory Syncytial Virus
- Human Metapneumovirus
- Bronchiolitis
- Viral Pneumonia
- Influenza Virus
- Viral Infections
- Vaccine Development
- Disease Burden
- Host Immune Response
- Epidemiology
- Research works
- 50k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 21.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +21% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Respiratory viral infections research research?
By volume, the United States and China publish the most (2.4k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.4k works
- 2 China 1.4k works
- 3 United Kingdom 485 works
- 4 India 343 works
- 5 Italy 341 works
- 6 Japan 315 works
- 7 Spain 312 works
- 8 France 287 works
- 9 Germany 276 works
- 10 Canada 262 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Respiratory viral infections research research?
By volume in 2022–2025, Pfizer (United States) publishes the most Respiratory viral infections research research, followed by University of North Carolina at Chapel Hill and Centers for Disease Control and Prevention.
By volume, 2022–2025
- 1 Pfizer (United States)United States 56 works
- 2 University of North Carolina at Chapel HillUnited States 51 works
- 3 Centers for Disease Control and PreventionUnited States 50 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 35 works
- 5 Emory UniversityUnited States 32 works
- 6 University of MichiganUnited States 31 works
- 7 Imperial College LondonUnited Kingdom 31 works
- 8 Vanderbilt University Medical CenterUnited States 27 works
- 9 Johns Hopkins UniversityUnited States 27 works
- 10 Merck & Co., Inc., Rahway, NJ, USA (United States)United States 26 works
Who are the leading researchers in Respiratory viral infections research?
The most-cited researchers publishing on Respiratory viral infections research include Ali H. Mokdad, Nelson Alvis‐Guzmán and Zulfiqar A Bhutta.
- 1 Ali H. Mokdad United States 10k citations
- 2 Nelson Alvis‐Guzmán Colombia 7.7k citations
- 3 Zulfiqar A Bhutta Pakistan 7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Respiratory viral infections research research done?
The largest centres of Respiratory viral infections research research in 2022–2025 are Beijing (China), London (United Kingdom), Atlanta (United States) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Rahway.
Largest cities, 2022–2025
Where it is the local speciality
- RahwayUS · 26.3 works33×
Location quotient: how much more of its research is in Respiratory viral infections research than the world average.
Where is the best place to study Respiratory viral infections research?
Among universities, judged by research, London School of Hygiene & Tropical Medicine, University of Georgia and University of Veterinary Medicine Hannover, Foundation score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | London School of Hygiene & Tropical MedicineUnited Kingdom | 65.9 | 29.8% | 11.1× | 16 | +55.9% |
| 2 | University of GeorgiaUnited States | 58.0 | 41.9% | 5.7× | 23 | +33.0% |
| 3 | University of Veterinary Medicine Hannover, FoundationGermany | 54.9 | 23.4% | 17.3× | 8 | +158.4% |
| 4 | Emory UniversityUnited States | 48.2 | 28.8% | 5.0× | 32 | -5.7% |
| 5 | Imperial College LondonUnited Kingdom | 48.2 | 27.4% | 3.7× | 31 | +5.4% |
| 6 | The University of Texas Medical Branch at GalvestonUnited States | 48.0 | 18.6% | 10.1× | 16 | +8.1% |
| 7 | Baylor College of MedicineUnited States | 47.0 | 34.5% | 4.8× | 18 | +21.2% |
| 8 | University of Hong KongHong Kong | 46.7 | 34.9% | 2.5× | 20 | -12.8% |
| 9 | Georgia State UniversityUnited States | 45.7 | 28.6% | 3.9× | 11 | +202.1% |
| 10 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 45.3 | 31.9% | 3.9× | 35 | -47.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Respiratory viral infections research research growing?
Output in 2018–2022 was 21% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Respiratory viral infections research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.